Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

5 results about "Anti-Allergic Agents" patented technology

Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (From AMA Drug Evaluations Annual, 1994, p475)

Low-irritation cyhalothrin as well as preparation method and application thereof

PendingCN120283752ABiocideAnimal repellantsAllergic antiAnti-Allergic Agents
The invention discloses low-irritation cyhalothrin and a preparation method and application thereof, and belongs to the technical field of pesticide preparations, the low-irritation cyhalothrin comprises silicon dioxide nanoparticles with the surfaces grafted with amphiphilic copolymers, cyhalothrin and an anti-allergic drug, the silicon dioxide nanoparticles with the surfaces grafted with the amphiphilic copolymers are dispersed in a solvent, and the anti-allergic drug is added to the silicon dioxide nanoparticles with the surfaces grafted with the amphiphilic copolymers to prepare the low-irritation cyhalothrin. The preparation method comprises the following steps: taking porous silicon dioxide nanoparticles as a carrier, modifying a layer of amphiphilic polymer on the surface of silicon dioxide in situ, then adding cyhalothrin and an anti-allergic drug, continuously stirring, and drying the obtained product to obtain the low-irritation cyhalothrin. The cyhalothrin and the anti-allergic drug are loaded in silicon dioxide pore channels, and the anti-allergic agent is used in cooperation, so that the skin irritation of the cyhalothrin is reduced. The cyhalothrin with low irritation provided by the invention is simple in preparation method, can be used as a cyhalothrin insecticide raw medicine, and has relatively great market application potential.
Owner:ANHUI NUMAI NEW MATERIALS TECHNOLOGY CO LTD

Pharmaceutical composition comprising a Pickering's oil-in-water emulsion containing an organomodified phyllosilicate, particularly for its use as an anti-inflammatory, healing, and anti-allergy agent.

PendingFR3168762A1Cosmetic preparationsNervous disorderVegetable oilAnti-Allergic Agents
Pharmaceutical composition comprising a Pickering oil-in-water emulsion containing an aqueous phase, a vegetable oil phase, and an organomodified phyllosilicate, particularly for its use in increasing TAFA4 production, and possibly for increasing serotonin production, for its use as a cutaneous anti-inflammatory agent and / or wound-healing agent and / or as a cutaneous anti-allergy agent. Figure to be published with the abstract: none.
Owner:EPHYLA SAS

Intestinal regulator, anti-allergic agent, immune enhancer, agent for improving the intestinal adhesion of lactic acid bacteria

To provide a medicine for intestinal disorders, an antiallergic agent, an immunoadjuvant and an agent for improving enteroadherent properties of lactic acid bacteria, which can be taken safely, are available inexpensively, and have high effect of improving enteroadherent properties of lactic acid bacteria.SOLUTION: An agent according to the present invention contains flower extract. The flower is a Lythraceae, Asteraceae, Fabaceae, Rosaceae or Iridaceae flower, preferably, at least one selected from Carthamus tinctorius, Punica granatum, Pueraria plants, Subgen. Cerasus plants, Chrysanthemum plants, Crocus sativus, Prunus persica Batsch and Rosa plants.SELECTED DRAWING: Figure 1
Owner:TOYO SHINYAKU KK

Composition for moisturizing and skin care and preparation method thereof

PendingCN121818482ACosmetic preparationsToilet preparationsAllergic antiAnti-Allergic Agents
The invention discloses a composition for moisturizing and protecting skin and a preparation method of the composition. Through the structure, the composition comprises 3%-8% of the moisturizing component, 2%-8% of the emulsifier and the stabilizer, 0.5%-2% of the pH regulator, 0.8%-3.5% of the preservative, 2%-5% of the ultraviolet light absorber, 4%-16% of the physical sun-screening agent, 0.1%-0.5% of the anti-allergic agent, 0.5%-2% of the cutin conditioner, 0.1%-1% of the antioxidant and the balance of the solvent. The skin can be quickly moistened, a long-time moisturizing effect can be provided, and the skin can be continuously kept moist; the skin care cream also has various skin care effects of resisting oxidation, blocking sun, resisting allergy, conditioning cutin and the like, and can provide all-around care for the skin.
Owner:王吉建

Bittern-coagulated tofu capable of inhibiting lipoxygenase, and preparation method therefor

The present application discloses bittern-coagulated tofu capable of inhibiting lipoxygenase, and a preparation method therefor. The bittern-coagulated tofu is composed of the following components in parts by weight: 50-100 parts of soybeans, 3-6 parts of a lipoxygenase inhibitor, 3-5 parts of an anti-allergic agent, 1-3 parts of cellulase, 0.1-0.3 parts of a defoaming agent, and 1-2 parts of a coagulator. Compared with commercially available bittern-coagulated tofu, the bittern-coagulated tofu capable of inhibiting lipoxygenase of the present application has lower lipoxygenase activity, lower health risk, smaller beany flavor, and better smell and taste.
Owner:SHANGHAI YIXING FOOD CO LTD